Objectives

After participating in this educational activity, attendees should be able to:
1. Understand the effects of mentored implementation of a medication reconciliation best practices toolkit on medication discrepancies across a wide range of North American hospitals.                                                                                                                                                                                                                                                                                                                                                                                                                       2. Appreciate how lessons learned from studies using implementation science methods can be applied to make subsequent quality improvement efforts more effective.

3.  Understand next steps to improve medication reconciliation nationwide

Faculty                                                                                                                                                                                                                                                                                                                                                                                                                 Jeffrey Schnipper, MD, MPH                                                                                                                                                                                                                                                                                                                                                                              Director of Clinical Research, Brigham Health Hospital Medicine Unit                                                                                                                                                                                                                                                                                                    Research Director, Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital                                                                                                                                                                                                                                   Associate Professor of Medicine, Harvard Medical School

Faculty Disclosure
None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.                                Dr. Schnipper has disclosed the following: Grant/Research Support: Mallinckrodt Pharmaceuticals (investigator-initiated study of opioid-related adverse drug events)Portola Pharmaceuticals (investigator-initiated study of patients who decline VTE prophylaxis)